258 related articles for article (PubMed ID: 20332120)
1. CCM1 regulates vascular-lumen organization by inducing endothelial polarity.
Lampugnani MG; Orsenigo F; Rudini N; Maddaluno L; Boulday G; Chapon F; Dejana E
J Cell Sci; 2010 Apr; 123(Pt 7):1073-80. PubMed ID: 20332120
[TBL] [Abstract][Full Text] [Related]
2. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
3. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
4. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
[TBL] [Abstract][Full Text] [Related]
5. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).
Kehrer-Sawatzki H; Wilda M; Braun VM; Richter HP; Hameister H
Acta Neuropathol; 2002 Sep; 104(3):231-40. PubMed ID: 12172908
[TBL] [Abstract][Full Text] [Related]
6. A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma.
Kitzmann AS; Pulido JS; Ferber MJ; Highsmith WE; Babovic-Vuksanovic D
Ophthalmic Genet; 2006 Dec; 27(4):157-9. PubMed ID: 17148043
[TBL] [Abstract][Full Text] [Related]
7. A novel CCM1 gene mutation causes cerebral cavernous malformation in a Chinese family.
Zhao Y; Xie L; Li P; Song J; Qu T; Fan W; Chen H; Chen D; Lu D; Zhou L; Mao Y
J Clin Neurosci; 2011 Jan; 18(1):61-5. PubMed ID: 20884211
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
Gault J; Sain S; Hu LJ; Awad IA
Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
[TBL] [Abstract][Full Text] [Related]
10. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis.
Lampugnani MG; Dejana E
Thromb Res; 2007; 120 Suppl 2():S1-6. PubMed ID: 18023702
[TBL] [Abstract][Full Text] [Related]
11. Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.
Glading AJ; Ginsberg MH
Dis Model Mech; 2010; 3(1-2):73-83. PubMed ID: 20007487
[TBL] [Abstract][Full Text] [Related]
12. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
13. VE-cadherin interacts with cell polarity protein Pals1 to regulate vascular lumen formation.
Brinkmann BF; Steinbacher T; Hartmann C; Kummer D; Pajonczyk D; Mirzapourshafiyi F; Nakayama M; Weide T; Gerke V; Ebnet K
Mol Biol Cell; 2016 Sep; 27(18):2811-21. PubMed ID: 27466317
[TBL] [Abstract][Full Text] [Related]
14. Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease.
Lampugnani MG; Dejana E; Giampietro C
Cold Spring Harb Perspect Biol; 2018 Oct; 10(10):. PubMed ID: 28851747
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells.
Noda K; Zhang J; Fukuhara S; Kunimoto S; Yoshimura M; Mochizuki N
Mol Biol Cell; 2010 Feb; 21(4):584-96. PubMed ID: 20032304
[TBL] [Abstract][Full Text] [Related]
16. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
17. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.
Faurobert E; Albiges-Rizo C
FEBS J; 2010 Mar; 277(5):1084-96. PubMed ID: 20096036
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell motility is compatible with junctional integrity.
Guo R; Sakamoto H; Sugiura S; Ogawa M
J Cell Physiol; 2007 May; 211(2):327-35. PubMed ID: 17167782
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
